1. Home
  2. ARMP vs SYPR Comparison

ARMP vs SYPR Comparison

Compare ARMP & SYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARMP
  • SYPR
  • Stock Information
  • Founded
  • ARMP N/A
  • SYPR 1997
  • Country
  • ARMP United States
  • SYPR United States
  • Employees
  • ARMP N/A
  • SYPR N/A
  • Industry
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • SYPR Industrial Machinery/Components
  • Sector
  • ARMP Health Care
  • SYPR Industrials
  • Exchange
  • ARMP Nasdaq
  • SYPR Nasdaq
  • Market Cap
  • ARMP 52.1M
  • SYPR 48.5M
  • IPO Year
  • ARMP N/A
  • SYPR 1994
  • Fundamental
  • Price
  • ARMP $2.22
  • SYPR $2.07
  • Analyst Decision
  • ARMP Strong Buy
  • SYPR
  • Analyst Count
  • ARMP 1
  • SYPR 0
  • Target Price
  • ARMP $9.00
  • SYPR N/A
  • AVG Volume (30 Days)
  • ARMP 18.4K
  • SYPR 45.7K
  • Earning Date
  • ARMP 08-12-2025
  • SYPR 08-12-2025
  • Dividend Yield
  • ARMP N/A
  • SYPR N/A
  • EPS Growth
  • ARMP N/A
  • SYPR N/A
  • EPS
  • ARMP N/A
  • SYPR N/A
  • Revenue
  • ARMP $4,699,000.00
  • SYPR $134,135,000.00
  • Revenue This Year
  • ARMP $8.43
  • SYPR N/A
  • Revenue Next Year
  • ARMP N/A
  • SYPR N/A
  • P/E Ratio
  • ARMP N/A
  • SYPR N/A
  • Revenue Growth
  • ARMP 14.24
  • SYPR N/A
  • 52 Week Low
  • ARMP $0.90
  • SYPR $1.30
  • 52 Week High
  • ARMP $3.42
  • SYPR $3.72
  • Technical
  • Relative Strength Index (RSI)
  • ARMP 63.56
  • SYPR 50.67
  • Support Level
  • ARMP $1.93
  • SYPR $2.09
  • Resistance Level
  • ARMP $2.24
  • SYPR $2.20
  • Average True Range (ATR)
  • ARMP 0.16
  • SYPR 0.18
  • MACD
  • ARMP 0.03
  • SYPR -0.02
  • Stochastic Oscillator
  • ARMP 104.55
  • SYPR 20.49

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

About SYPR Sypris Solutions Inc.

Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.

Share on Social Networks: